Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Advantage Solutions A | ADV | Oct 30, 2024 | 3.15 | +1.29 |
Advent | AVK | Oct 30, 2024 | 11.15 | -0.18 |
Advent Technologies A | ADN | Oct 30, 2024 | 1.78 | +1.14 |
Adverum Biotechnologies | ADVM | Oct 30, 2024 | 7.88 | +1.55 |
AdvisorShares Pure US Cannabis ETF | MSOS | Oct 30, 2024 | 6.69 | -1.62 |
Advisorshares Star Global Buy-Write ETF | VEGA | Oct 30, 2024 | 43.57 | -0.08 |
AECOM | ACM | Oct 30, 2024 | 107.37 | -1.01 |
Aegon N.V ADR | AEG | Oct 30, 2024 | 6.33 | -0.63 |
Aehr Test Systems | AEHR | Oct 30, 2024 | 14.79 | -7.27 |
Aemetis | AMTX | Oct 30, 2024 | 2.71 | -0.73 |
Aeon Biopharma | AEON | Oct 30, 2024 | 0.92 | -5.95 |
AerCap Holdings | AER | Oct 30, 2024 | 93.89 | -1.91 |
Aeries Technology | AERT | Oct 30, 2024 | 1.65 | -2.37 |
Aerospace & Defense Powershares | PPA | Oct 30, 2024 | 115.94 | -0.18 |
Aerovate Therapeutics | AVTE | Oct 30, 2024 | 2.19 | -3.10 |
AeroVironment | AVAV | Oct 30, 2024 | 216.60 | -1.92 |
AerSale | ASLE | Oct 30, 2024 | 5.40 | -0.92 |
AES | AES | Oct 30, 2024 | 16.42 | -0.61 |
Aetherium Acquisition A | GMFI | Oct 30, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Oct 30, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Oct 30, 2024 | 0.40 | +2.75 |
Aeva Technologies | AEVA | Oct 30, 2024 | 4.00 | -4.99 |
AEye A | LIDR | Oct 30, 2024 | 1.13 | -3.83 |
AFC Gamma | AFCG | Oct 30, 2024 | 9.97 | +1.32 |
Affiliated Managers Group | AMG | Oct 30, 2024 | 196.32 | +0.39 |
Affimed N.V. | AFMD | Oct 30, 2024 | 3.34 | -0.30 |
Affinity Bancshares | AFBI | Oct 30, 2024 | 21.40 | +0.05 |
Affirm A | AFRM | Oct 30, 2024 | 45.24 | +5.53 |
Aflac | AFL | Oct 30, 2024 | 110.09 | +0.08 |
Africa Index ETF Market Vectors | AFK | Oct 30, 2024 | 16.71 | -0.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.